Skip to main content
INVION LIMITED logo

INVION LIMITED — Investor Relations & Filings

Ticker · IVX ISIN · AU000000IVX4 LEI · 529900JY0HVEQEMSSJ32 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,119 across all filing types
Latest filing 2022-06-19 Share Issue/Capital Cha…
Country AU Australia
Listing ASX IVX

About INVION LIMITED

https://inviongroup.com

Invion Limited is a life sciences company dedicated to the development and commercialization of Photosoft technology, a next-generation Photodynamic Therapy (PDT). The company focuses on utilizing this light-activated treatment platform to target various forms of cancer and infectious diseases. Photosoft technology is derived from natural chlorophyll and is designed to selectively destroy malignant cells while minimizing damage to healthy tissue. Invion's research and development efforts are primarily directed toward oncology applications, including the treatment of skin, lung, and ovarian cancers, as well as addressing global health challenges through the treatment of viral and bacterial infections. The company aims to provide non-invasive or minimally invasive therapeutic alternatives that offer improved patient outcomes and reduced side effects compared to conventional treatment modalities.

Recent filings

Filing Released Lang Actions
Notification regarding unquoted securities - IVX 9 pages 33.0KB
Share Issue/Capital Change Classification · 95% confidence The document is a notification regarding the issue of unquoted equity securities, specifically options issued in lieu of directors' fees. It details the number of securities issued, the terms, and references shareholder approval at the AGM. The content focuses on the issuance of new securities and related details rather than financial results, management changes, or legal matters. This fits the definition of a Share Issue/Capital Change (SHA) filing, which covers announcements about new share issues or capital changes. The document length is sufficient and contains substantive details about the securities issued, confirming it is not a mere announcement of a report or a certification. Therefore, the correct classification is SHA with high confidence.
2022-06-19 English
International Patent to Extend IP Protection for Photosoft 2 pages 155.7KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement from Invion Limited regarding the publication of an international patent application covering their clinical drug candidate INV043. It discusses the novelty and industrial applicability of the patent claims, the extension of intellectual property protection, and the potential commercial and partnership opportunities arising from this patent. There are no financial statements, quarterly or annual results, or management discussion of financial performance. The document is primarily a regulatory announcement about intellectual property and business development, not a financial report or earnings release. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is a regulatory announcement about a patent and business update, which fits best under Regulatory Filings (RNS). The document length is about 5999 characters, which is not extremely short, but the content is clearly an announcement rather than a report or presentation. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2022-06-07 English
INV043 SIGNIFICANTLY IMPROVED CHECKPOINT INHIBITOR THERAPY 6 pages 1.5MB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement from Invion Limited detailing the results of a Proof-of-Concept study on the combination therapy of INV043 with immune checkpoint inhibitors (ICI). It includes scientific findings, study details, and implications for future clinical applications and partnerships. The document is a public announcement of research results and does not contain comprehensive financial data, regulatory certifications, or detailed financial statements. It is not a full annual or interim report, nor is it a transcript, audit report, or governance document. The content focuses on research findings and strategic implications rather than financial performance or management changes. Therefore, the document fits best as a Regulatory Filing (RNS), which is a general regulatory announcement category for filings that do not neatly fit into other specific categories.
2022-05-29 English
Activities Report and Appendix 4C 8 pages 299.4KB
Interim / Quarterly Report Classification · 100% confidence The document is an ASX announcement titled 'Activity Report and Cash Flow Report for the Quarter Ended 31 March 2022'. It includes detailed financial data such as cash flow statements from operating, investing, and financing activities, as well as a summary of cash position and expenditure during the quarter. The presence of Appendix 4C, which is a standard quarterly cash flow report required by ASX Listing Rule 4.7B, confirms this is a quarterly financial report. The document contains substantive financial data and analysis for a period shorter than a full fiscal year (the quarter ended 31 March 2022). Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q3 2022
2022-04-19 English
Results of General Meeting 2 pages 127.8KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an ASX release dated 29 March 2022, titled 'RESULTS OF GENERAL MEETING'. It provides detailed voting results for resolutions passed at a general meeting, including percentages of votes for, against, and abstentions. The text references compliance with Listing Rule 3.13.2 and Section 251AA of the Corporations Act, which relate to disclosure of voting outcomes. The document is short (3120 characters) and focuses solely on the announcement of voting results rather than the meeting materials or the meeting itself. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2022-03-28 English
Notification regarding unquoted securities - IVX 9 pages 33.1KB
Share Issue/Capital Change Classification · 95% confidence The document is a detailed notification about the issue of unquoted equity securities (options) by Invion Limited. It includes specifics such as the number of securities issued, the nature of the securities (unquoted options), the issue date, and the purpose (in lieu of directors fees). It references shareholder approval at the AGM but is not itself an AGM presentation or voting result. The document is a formal announcement of a securities issuance, which fits the category of Share Issue/Capital Change filings. It is not a full financial report, audit, or earnings release, nor is it a regulatory certification or legal proceeding. Therefore, the most appropriate classification is Share Issue/Capital Change (SHA). The document length and detail support a high confidence in this classification.
2022-03-20 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.